FDA orders starker warnings on opioid painkillers
WASHINGTON (AP) — The Food and Drug Administration is requiring stronger warning labels on prescription painkillers like OxyContin, in the government's latest attempt to reduce overdose deaths caused by the long-acting medications. The changes announced Tuesday are designed to remind doctors and patients about the fatal risks of misusing and abusing long-acting opioid pain relievers, which include forms of oxycodone, morphine and other narcotic medications. Whereas the previous label recommended the medications for "moderate to severe pain," the new label describes a more limited role. It says the drugs should only be used for "pain severe enough to require daily, around-the-clock" treatment that cannot be managed with alternatives, such as over-the-counter medications or immediate-release opioids.
- Will More Pioneer ACOs Defect?
- Interventional Radiology No Longer a Sub-Specialty
- Charity HealthCare Conundrum Brewing Among Providers
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- Acute Kidney Injury Gets New Focus
- CNO Leads $1M Charge for New Scrubs, Uniforms
- mHealth Tackles Readmissions
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013